APA (7th ed.) Citation

M, K., A, V., S, V., DW, V., E, M., & M, N. (2024). Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22(6), 1330. https://doi.org/10.1016/j.cgh.2023.11.003

Chicago Style (17th ed.) Citation

M, Kalligeros, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, and Noureddin M. "Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020." Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22, no. 6 (2024): 1330. https://doi.org/10.1016/j.cgh.2023.11.003.

MLA (9th ed.) Citation

M, Kalligeros, et al. "Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020." Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 22, no. 6, 2024, p. 1330, https://doi.org/10.1016/j.cgh.2023.11.003.